Table 5.
Association between mgmiRs and clinicopathologcal characteristics in HNSCC saliva
| mgmiR9-1 %(n) |
mgmiR124-1 %(n) |
mgmiR124-2 %(n) |
mgmiR124-3 %(n) |
mgmiR129-2 %(n) |
mgmiR137 %(n) |
mgmiR148a %(n) |
Combined mgmiRs %(n) |
|
|---|---|---|---|---|---|---|---|---|
| Location | ||||||||
| OSCC (42) | 40.5(17) | 69.1(29) | 45.2(19) | 40.5(17) | 73.8(31) | 31.0(13) | 26.2(11) | 71.4(30) |
| OPSCC (28) | 57.1(16) | 57.1(16) | 46.4(13) | 64.3(18) | 67.9(19) | 32.1(9) | 17.9(5) | 82.1(23) |
| LSCC (13) | 53.9(7) | 84.6(11) | 46.2(6) | 61.5(8) | 69.2(9) | 46.2(6) | 7.70(1) | 76.9(10) |
| Smoking | ||||||||
| Never (17) | 64.7(11) | 70.6(12) | 52.9(9) | 58.8(10) | 64.7(11) | 35.3(6) | 11.8(2) | 82.4(14) |
| Current (21) | 52.4(11) | 66.7(14) | 28.6(6) | 57.1(12) | 81.0(17) | 19.1(4) | 23.8(5) | 76.2(16) |
| Ex (48) | 41.7(20) | 64.6(31) | 50.0(24) | 50.0(24) | 70.8(34) | 39.6(19) | 20.8(10) | 75.0(36) |
| Tumor size | ||||||||
| T1 (20) | 55.0(11) | 65.0(13) | 30.0(6) | 55.0(11) | 75.0(15) | 35.0(7) | 30.0(6) | 85.0(17) |
| T2 (26) | 38.5(10) | 61.5(16) | 57.7(15) | 42.3(11) | 73.1(19) | 34.6(9) | 19.2(5) | 73.1(19) |
| T3 (11) | 45.5(5) | 72.7(8) | 45.5(5) | 63.6(7) | 72.7(8) | 45.5(5) | 18.2(2) | 63.6(7) |
| T4 (21) | 42.9(9) | 76.2(16) | 47.6(10) | 47.6(10) | 61.9(13) | 28.6(6) | 14.3(3) | 71.4(15) |
| Node status | ||||||||
| N0 (28) | 57.1(16) | 67.9(19) | 39.3(11) | 50.0(14) | 75.0(21) | 32.1(9) | 14.3(4) | 75.0(21) |
| N+ (48) | 35.4(17) | 68.8(33) | 52.1(25) | 47.9(23) | 66.7(32) | 37.5(18) | 25.0(12) | 72.9(35) |
| Stage | ||||||||
| I (10) | 60.0(6) | 80.0 (8) | 30.0(3) | 40.0(4) | 80.0(8) | 40.0(4) | 20.0(2) | 80.0(8) |
| II (13) | 46.2(6) | 53.9(7) | 53.9(7) | 53.9(7) | 76.9(10) | 23.1(3) | 23.1(3) | 69.2(9) |
| III (17) | 47.1(8) | 52.9(9) | 41.2(7) | 52.9(9) | 64.7(11) | 41.2(7) | 11.8(2) | 76.5(13) |
| IV (36) | 36.1(13) | 77.8(28) | 52.8(19) | 47.2(17) | 66.7(24) | 36.1(13) | 25.0 (9) | 72.2(26) |